Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
Seagen Inc.
Corvus Pharmaceuticals, Inc.
Hoffmann-La Roche
Seagen Inc.
Novartis
Turning Point Therapeutics, Inc.
Takeda
Pfizer
Bristol-Myers Squibb
Boehringer Ingelheim
BeiGene
Takeda
Takeda
Seagen Inc.
Tessa Therapeutics
Seagen Inc.
Takeda
Takeda
Seagen Inc.
Takeda
Novartis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Takeda
Novartis
Immune Cell, Inc.
Seagen Inc.
Seagen Inc.
Seagen Inc.
Progen Pharmaceuticals
Morphotek
Seagen Inc.
Seagen Inc.
Seagen Inc.
Seagen Inc.
Seagen Inc.
Xencor, Inc.
INSYS Therapeutics Inc
Bristol-Myers Squibb